These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 1981393

  • 41. Limonene has anti-anxiety activity via adenosine A2A receptor-mediated regulation of dopaminergic and GABAergic neuronal function in the striatum.
    Song Y, Seo S, Lamichhane S, Seo J, Hong JT, Cha HJ, Yun J.
    Phytomedicine; 2021 Mar; 83():153474. PubMed ID: 33548867
    [Abstract] [Full Text] [Related]

  • 42. GABA and the behavioral effects of anxiolytic drugs.
    Sanger DJ.
    Life Sci; 1985 Apr 22; 36(16):1503-13. PubMed ID: 2858804
    [Abstract] [Full Text] [Related]

  • 43. Dihydropicrotoxinin binding sites in mammalian brain: interaction with convulsant and depressant benzodiazepines.
    Leeb-Lundberg F, Napias C, Olsen RW.
    Brain Res; 1981 Jul 20; 216(2):399-408. PubMed ID: 6113878
    [Abstract] [Full Text] [Related]

  • 44. [Functional aspects of the interaction between benzodiazepines and their central receptors].
    Soubrié P.
    Encephale; 1983 Jul 20; 9(4 Suppl 2):183B-190B. PubMed ID: 6327228
    [Abstract] [Full Text] [Related]

  • 45. Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish-Involvement of GABAergic and 5-HT systems.
    Benneh CK, Biney RP, Mante PK, Tandoh A, Adongo DW, Woode E.
    J Ethnopharmacol; 2017 Jul 31; 207():129-145. PubMed ID: 28645783
    [Abstract] [Full Text] [Related]

  • 46. Receptors for the age of anxiety: pharmacology of the benzodiazepines.
    Tallman JF, Paul SM, Skolnick P, Gallager DW.
    Science; 1980 Jan 18; 207(4428):274-81. PubMed ID: 6101294
    [Abstract] [Full Text] [Related]

  • 47. The anxiolytic beta-carboline ZK 93423 prevents the stress-induced increase in dopamine turnover in the prefrontal cortex.
    Giorgi O, Corda MG, Biggio G.
    Eur J Pharmacol; 1987 Feb 24; 134(3):327-31. PubMed ID: 2883014
    [Abstract] [Full Text] [Related]

  • 48. Comparative neuropharmacology of antianxiety drugs.
    Paul SM, Skolnick P.
    Pharmacol Biochem Behav; 1982 Feb 24; 17 Suppl 1():37-41. PubMed ID: 6135226
    [Abstract] [Full Text] [Related]

  • 49. The GABAA receptor: new insights from single-channel recording.
    Mathers DA.
    Synapse; 1987 Feb 24; 1(1):96-101. PubMed ID: 2905528
    [Abstract] [Full Text] [Related]

  • 50. Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour.
    File SE.
    Neuropsychobiology; 1985 Feb 24; 13(1-2):55-62. PubMed ID: 2863779
    [Abstract] [Full Text] [Related]

  • 51. Benzodiazepine interactions with GABA receptors.
    Haefely W.
    Neurosci Lett; 1984 Jun 29; 47(3):201-6. PubMed ID: 6147796
    [Abstract] [Full Text] [Related]

  • 52. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.
    Dennis T, Curet O, Nishikawa T, Scatton B.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 29; 331(2-3):225-34. PubMed ID: 3003590
    [Abstract] [Full Text] [Related]

  • 53. The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex.
    Ticku MK, Burch TP, Davis WC.
    Pharmacol Biochem Behav; 1983 Nov 29; 18 Suppl 1():15-8. PubMed ID: 6138771
    [Abstract] [Full Text] [Related]

  • 54. Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.
    Dazzi L, Ladu S, Spiga F, Vacca G, Rivano A, Pira L, Biggio G.
    Synapse; 2002 Jan 29; 43(1):70-7. PubMed ID: 11746735
    [Abstract] [Full Text] [Related]

  • 55. Central α- and β-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks.
    Rivera EM, Cid MP, Zunino P, Baiardi G, Salvatierra NA.
    Brain Res; 2014 Mar 25; 1555():28-35. PubMed ID: 24486357
    [Abstract] [Full Text] [Related]

  • 56. Anxiogenic and non-anxiogenic benzodiazepine antagonists.
    Prado de Carvalho LP, Grecksch G, Chapouthier G, Rossier J.
    Nature; 1983 Jan 06; 301(5895):64-6. PubMed ID: 6296684
    [Abstract] [Full Text] [Related]

  • 57. The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice.
    Sasaki K, Fan LW, Tien LT, Ma T, Loh HH, Ho IK.
    Brain Res Bull; 2002 Mar 15; 57(5):689-94. PubMed ID: 11927374
    [Abstract] [Full Text] [Related]

  • 58. Participation of GABA in the mechanism of action of psychotropic agents.
    Zakusov VV, Ostrovskaya RU, Bulayev VM.
    Acta Physiol Pharmacol Bulg; 1982 Mar 15; 8(1-2):7-12. PubMed ID: 6126996
    [No Abstract] [Full Text] [Related]

  • 59. GABA-A receptor complex and memory processes.
    Chapouthier G, Venault P.
    Curr Top Med Chem; 2002 Aug 15; 2(8):841-51. PubMed ID: 12171575
    [Abstract] [Full Text] [Related]

  • 60. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1.
    Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, Schumacher M, von Wolff G, Avrabos C, Touma C, Engblom D, Schütz G, Nave KA, Eder M, Wotjak CT, Sillaber I, Holsboer F, Wurst W, Deussing JM.
    Science; 2011 Sep 30; 333(6051):1903-7. PubMed ID: 21885734
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.